Lazard Asset Management LLC Has $160.51 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Lazard Asset Management LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 8.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,107,657 shares of the medical instruments supplier’s stock after buying an additional 745,421 shares during the quarter. Lazard Asset Management LLC owned approximately 5.07% of DENTSPLY SIRONA worth $160,508,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of XRAY. Brooklyn Investment Group purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA in the 1st quarter worth about $26,000. Trust Co. of Toledo NA OH purchased a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth about $27,000. Parkside Financial Bank & Trust lifted its holdings in shares of DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,477 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in shares of DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 2,241 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of research reports. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Stifel Nicolaus set a $13.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, November 6th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Finally, Wells Fargo & Company lowered their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Friday, November 7th. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Reduce” and a consensus price target of $15.77.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $11.57 on Friday. The firm has a market capitalization of $2.31 billion, a PE ratio of -2.62, a PEG ratio of 0.85 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $20.59. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. The firm’s fifty day simple moving average is $11.75 and its 200 day simple moving average is $13.77.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The firm’s revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.